2024-11-01 2025-10-31 2025-10-31 false 07051144 LEEMING ENTERPRISES LIMITED 68209Other letting and operating of own or leased real estate iso4217:GBP xbrli:pure 070511442024-11-01 070511442025-10-31 070511442024-11-01 2025-10-31 07051144bus:SmallEntities2024-11-01 2025-10-31 07051144bus:AuditExempt-NoAccountantsReport2024-11-01 2025-10-31 07051144bus:FullAccounts2024-11-01 2025-10-31 07051144core:WithinOneYear2025-10-31 07051144core:AfterOneYear2025-10-31 07051144core:WithinOneYear2024-11-01 2025-10-31 07051144core:AfterOneYear2024-11-01 2025-10-31 07051144core:CurrentFinancialInstruments2025-10-31 07051144core:Non-currentFinancialInstruments2025-10-31 07051144core:CurrentFinancialInstruments2024-11-01 2025-10-31 07051144core:Non-currentFinancialInstruments2024-11-01 2025-10-31 07051144core:LandBuildings2024-11-01 2025-10-31 07051144core:FurnitureFittings2024-11-01 2025-10-31 07051144core:OfficeEquipment2024-11-01 2025-10-31 07051144core:Vehicles2024-11-01 2025-10-31 07051144core:PlantMachinery2024-11-01 2025-10-31 07051144core:OtherPropertyPlantEquipment2024-11-01 2025-10-31 07051144core:LandBuildings2025-10-31 07051144core:PlantMachinery2025-10-31 07051144core:Vehicles2025-10-31 07051144core:FurnitureFittings2025-10-31 07051144core:OfficeEquipment2025-10-31 07051144core:OtherPropertyPlantEquipment2025-10-31 07051144core:Right-of-useAssets2024-11-01 2025-10-31 07051144core:Right-of-useAssets2025-10-31 07051144core:Goodwill2024-11-01 2025-10-31 07051144core:PatentsTrademarksLicencesConcessionsSimilar2024-11-01 2025-10-31 07051144core:DevelopmentCostsCapitalisedDevelopmentExpenditure2024-11-01 2025-10-31 07051144core:OtherResidualIntangibleAssets2024-11-01 2025-10-31 07051144core:Goodwill2025-10-31 07051144core:DevelopmentCostsCapitalisedDevelopmentExpenditure2025-10-31 07051144core:PatentsTrademarksLicencesConcessionsSimilar2025-10-31 07051144core:OtherResidualIntangibleAssets2025-10-31 07051144dpl:CostSales2024-11-01 2025-10-31 07051144dpl:AdministrativeExpenses2024-11-01 2025-10-31 07051144dpl:DistributionCosts2024-11-01 2025-10-3107051144core:ShareCapital2025-10-31 07051144core:SharePremium2025-10-31 07051144core:RevaluationReserve2025-10-31 07051144core:OtherReservesSubtotal2025-10-31 07051144core:ShareCapitalPreferenceShares2025-10-31 07051144core:CapitalRedemptionReserve2025-10-31 07051144core:OtherCapitalReserve2025-10-31 07051144core:RetainedEarningsAccumulatedLosses2025-10-3107051144core:ShareCapital2024-11-01 2025-10-31 07051144core:SharePremium2024-11-01 2025-10-31 07051144core:RevaluationReserve2024-11-01 2025-10-31 07051144core:OtherReservesSubtotal2024-11-01 2025-10-31 07051144core:RetainedEarningsAccumulatedLosses2024-11-01 2025-10-310705114412024-11-01 2025-10-31 0705114422024-11-01 2025-10-3107051144core:ShareCapital12024-11-01 2025-10-31 07051144core:ShareCapital22024-11-01 2025-10-3107051144core:SharePremium12024-11-01 2025-10-31 07051144core:SharePremium22024-11-01 2025-10-3107051144core:RevaluationReserve12024-11-01 2025-10-31 07051144core:RevaluationReserve22024-11-01 2025-10-3107051144core:RetainedEarningsAccumulatedLosses12024-11-01 2025-10-31 07051144core:RetainedEarningsAccumulatedLosses22024-11-01 2025-10-310705114412024-11-01 2025-10-3107051144core:Non-currentFinancialInstrumentscore:CostValuation2024-11-01 07051144core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-10-31 07051144core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-10-31 07051144core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-10-31 07051144core:Non-currentFinancialInstrumentscore:TransfersIntoOrOutInvestmentsIncreaseDecreaseInInvestments2025-10-31 07051144core:Non-currentFinancialInstrumentscore:CostValuation2025-10-3107051144core:Non-currentFinancialInstrumentscore:ProvisionsForImpairmentInvestments2024-11-01 07051144core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-10-31 07051144core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-10-31 07051144core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-10-31 07051144core:Non-currentFinancialInstrumentscore:FurtherSpecificIncreaseDecreaseInProvisionsForImpairmentInvestments1ComponentCorrespondingTotal2025-10-31 07051144core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-10-31 07051144core:Non-currentFinancialInstrumentscore:ProvisionsForImpairmentInvestments2025-10-3107051144core:Non-currentFinancialInstruments2025-10-31 07051144core:Non-currentFinancialInstruments2024-10-31070511442023-11-01 070511442024-10-31 070511442023-11-01 2024-10-31 07051144core:WithinOneYear2024-10-31 07051144core:AfterOneYear2024-10-31 07051144core:CurrentFinancialInstruments2024-10-31 07051144core:Non-currentFinancialInstruments2024-10-31 07051144core:LandBuildings2024-10-31 07051144core:PlantMachinery2024-10-31 07051144core:Vehicles2024-10-31 07051144core:FurnitureFittings2024-10-31 07051144core:OfficeEquipment2024-10-31 07051144core:OtherPropertyPlantEquipment2024-10-31 07051144core:Right-of-useAssets2024-10-31 07051144core:Goodwill2024-10-31 07051144core:DevelopmentCostsCapitalisedDevelopmentExpenditure2024-10-31 07051144core:PatentsTrademarksLicencesConcessionsSimilar2024-10-31 07051144core:OtherResidualIntangibleAssets2024-10-31 07051144dpl:AdministrativeExpenses2023-11-01 2024-10-3107051144core:ShareCapital2024-10-31 07051144core:SharePremium2024-10-31 07051144core:RevaluationReserve2024-10-31 07051144core:OtherReservesSubtotal2024-10-31 07051144core:ShareCapitalPreferenceShares2024-10-31 07051144core:CapitalRedemptionReserve2024-10-31 07051144core:OtherCapitalReserve2024-10-31 07051144core:RetainedEarningsAccumulatedLosses2024-10-3107051144core:RetainedEarningsAccumulatedLosses2023-11-01 07051144core:ShareCapital2023-11-01 07051144core:SharePremium2023-11-01 07051144core:RevaluationReserve2023-11-01 07051144core:ShareCapital2023-11-01 2024-10-31 07051144core:SharePremium2023-11-01 2024-10-31 07051144core:RevaluationReserve2023-11-01 2024-10-31 07051144core:OtherReservesSubtotal2023-11-01 2024-10-31 07051144core:RetainedEarningsAccumulatedLosses2023-11-01 2024-10-3107051144bus:Director12024-11-01 2025-10-3107051144bus:PrivateLimitedCompanyLtd2024-11-01 2025-10-31
LEEMING ENTERPRISES LIMITED
Unaudited Financial Statements
for the year ended 31 October 2025
Company registration number 07051144
(England and Wales)

Company Information

For the year ended 31 October 2025
Director Leeming, Malcolm John

Registered office Wycongill Farm Holden Lane
Bolton By Bowland
Clitheroe
BB7 4LZ

Registered number 07051144

Accountant H & M Ltd
The Four Columns
Broughton Hall Business Park
Skipton
Skipton
North Yorkshire
BD23 3AE

Statement of Financial Position

As at 31 October 2025
Notes
2025
2024
£
£
£
£
Fixed assets
Tangible assets
742,352
744,113
742,352
744,113
Current assets
Debtors
4
1,063
896
Cash at bank and in hand
22,173
41,361
23,236
42,257
Creditors
Amounts falling due within one year
5
(22,915)
(19,598)
(22,915)
(19,598)
Net current assets (liabilities)
321
22,659
Total assets less current liabilities
742,673
766,772
Creditors
Amounts falling due after one year
6
(665,408)
(726,502)
(665,408)
(726,502)
Provisions for liabilities
(1,996)
(2,230)
Net assets (liabilities)
75,269
38,040
Capital and reserves
Called up share capital
1
1
Profit and loss account
75,268
38,039
Total equity
75,269
38,040

The company is a private company limited by shares and registered in England and Wales. It was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
The financial statements have been prepared in accordance with the special provisions applicable to companies subject to the small companies regime.
The directors have chosen to not file a copy of the company's profit and loss account under section 444 (5A) of the Companies Act 2006.

The financial statements were approved and authorised for issue by the Board of Directors on 1 June 2026 and are signed on its behalf by:

Leeming, Malcolm John
Leeming, Malcolm John
Director

Company registration number 07051144

Notes to the Financial Statements

For the year ended 31 October 2025

1. Statutory information

The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The financial statements are presented in sterling and this is the functional currency of the company.

2. Accounting policies

2.1. Basis of preparation

The financial statements have been prepared in accordance with FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.

The financial statements have been prepared under the historical cost convention in accordance with the Companies Act 2006.

2.2. Turnover

Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.


Revenue from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.

2.3. Current taxation

Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income.


Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.

2.4. Deferred tax

Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.

2.5. Tangible fixed assets and depreciation

All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Rate
Method
%
Plant and machinery
15
Reducing balance

2.6. Impairment

The directors assess the company's tangible assets for evidence of impairment at each reporting date. Where there are indicators of impairment, the directors calculate recoverable amount of the asset(s) and compare this with the carrying amount. If the recoverable amount is lower than carrying amount, the asset is written down to recoverable amount by way of an impairment loss which is recognised in profit or loss for the period.


Impairment losses are reversed when there is evidence that the reasons giving rise to the original impairment have ceased to apply. Impairment losses are reversed through profit and loss but only to the extent that the reversal does not increase the carrying amount of the asset to the amount which would have been stated, net of depreciation, had no impairment loss been recognised.

2.7. Financial instruments

The following assets and liabilities are classified as financial instruments - trade debtors, trade creditors, bank loans and directors' loans.

 

Bank loans are initially measured at the present value of future payments, discounted at a market rate of interest, and subsequently at amortised cost using the effective interest method.

 

Directors' loans (being repayable on demand), trade debtors and trade creditors are measured at the undiscounted amount of the cash or other consideration expected to be paid or received.


Financial assets that are measured at amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in the Income Statement.

 


3. Employees

The average number of employees during the year was 1 (2024: 1).

4. Debtors

2025
2024
£
£
Prepayments and accrued income
1,063
896
Total due within one year
1,063
896
Total due after one year
-
-
Total
1,063
896

5. Creditors due within one year

2025
2024
£
£
Trade creditors
930
883
Other creditors
19,507
15,500
Taxation and social security
2,478
3,215
Total
22,915
19,598

6. Creditors due after one year

2025
2024
£
£
Directors loan account
665,408
726,502
Total
665,408
726,502